Latest Men's Health News

18Oct
2023

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health DangersWEDNESDAY, Oct. 18, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has proposed a ban on the use of formaldehyde in hair relaxers over concerns about its link to respiratory problems and certain cancers.Right now, the FDA only discourages using such hair-straightening products, which are typically used by Black women.Recent research has helped raise awareness about the potential dangers of using chemical hair relaxers.“We know that these products are very poorly regulated by the federal government in terms of what goes in there,” said Kimberly Bertrand, an associate professor of medicine at Boston University School of Medicine and the lead author of a recently published study on the dangers of relaxers. “You can’t look at an ingredient label and know that it...

Could a Warming Climate Bring Yellow Fever to America?

18 October 2023
Could a Warming Climate Bring Yellow Fever to America?WEDNESDAY, Oct. 18, 2023 (HealthDay News) -- Yellow fever may be resurfacing in the United States, thanks to climate change.The mosquito-borne viral illness decimated southern U.S. cities from 1820 to 1905, and now a new report says it could return to those areas.One of the potential reasons for a yellow fever resurgence? Global warming, because mosquitoes love warm, wet weather.Exactly where yellow fever may turn up in the United States is not known, but historically outbreaks occur in the southern U.S. along ports such as New Orleans, Galveston, Texas, and along the Mississippi River, said study author Dr. Peter Hotez. He is the dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine...

Commonly Used Drug Might Be New Treatment Option for IBS

18 October 2023
Commonly Used Drug Might Be New Treatment Option for IBSWEDNESDAY, Oct. 18, 2023 (HealthDay News) -- An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS).In the study, British researchers found that those taking amitriptyline were almost twice as likely as those taking a placebo to see an improvement in IBS symptoms.“We were delighted that the drug was both effective and safe for IBS when used at a low dose and titrated [slowly increased],” said Dr. Alexander Ford, a professor of gastroenterology at Leeds Institute of Medical Research at St. James's at the University of Leeds.About 1 in 20 people worldwide live with the abdominal pain and bowel issues that are hallmarks of IBS, a chronic...

Obesity Raises Odds for Recurrence in Breast Cancer Survivors

18 October 2023
Obesity Raises Odds for Recurrence in Breast Cancer SurvivorsWEDNESDAY, Oct. 18, 2023 (HealthDay News) -- Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs may be less effective in women who are obese.Breast cancer cells in hormone-positive breast cancers are fueled by the female sex hormone estrogen. Aromatase inhibitor medications lower estrogen levels by stopping an enzyme in fat tissue called aromatase from changing other hormones into estrogen. When compared to breast cancer survivors of normal weight, women who were obese were 18% more likely to have a recurrence even when taking an aromatase inhibitor, and this increased risk was even higher among survivors who were severely obese, the investigators found.“Postmenopausal women with hormone...
RSS
123468910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.